Healthcare provider profile · identity verified

W. Hugh Morgan, M.D.

Family Practice · JOHNSTON, SC · NPI 1316974587

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	439	79
Atorvastatin Calcium	Atorvastatin Calcium	431	108
Ezetimibe	Ezetimibe	380	86
Lisinopril	Lisinopril	342	66
Levothyroxine Sodium	Levothyroxine Sodium	319	58
Rosuvastatin Calcium	Rosuvastatin Calcium	281	57
Tamsulosin Hcl	Tamsulosin Hcl	238	51
Metformin Hcl	Metformin Hcl	228	49
Omeprazole	Omeprazole	226	64
Sertraline Hcl	Sertraline Hcl	210	38
Simvastatin	Simvastatin	175	35
Metoprolol Succinate	Metoprolol Succinate	171	43
Potassium Chloride	Potassium Chloride	170	36
Pravastatin Sodium	Pravastatin Sodium	168	34
Gabapentin	Gabapentin	167	42
Meloxicam	Meloxicam	161	39
Allopurinol	Allopurinol	150	29
Irbesartan	Irbesartan	133	22
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	128	23
Furosemide	Furosemide	122	33
Eliquis	Apixaban	111	20
Hydralazine Hcl	Hydralazine Hcl	109	20
Hydrochlorothiazide	Hydrochlorothiazide	103	24
Diclofenac Sodium	Diclofenac Sodium	93	25
Pantoprazole Sodium	Pantoprazole Sodium	92	26
Trazodone Hcl	Trazodone Hcl	82	14
Celecoxib	Celecoxib	81	21
Esomeprazole Magnesium	Esomeprazole Magnesium	79	16
Montelukast Sodium	Montelukast Sodium	77	23
Fluoxetine Hcl	Fluoxetine Hcl	74	12
Paroxetine Hcl	Paroxetine Hcl	74	12
Atenolol	Atenolol	67	suppressed
Ropinirole Hcl	Ropinirole Hcl	67	16
Donepezil Hcl	Donepezil Hcl	66	16
Duloxetine Hcl	Duloxetine Hcl	65	16
Glipizide	Glipizide	64	12
Carvedilol	Carvedilol	61	15
Valsartan	Valsartan	59	12
Januvia	Sitagliptin Phosphate	58	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	13
Sucralfate	Sucralfate	56	26
Metoprolol Tartrate	Metoprolol Tartrate	55	13
Finasteride	Finasteride	52	11
Oxybutynin Chloride Er	Oxybutynin Chloride	51	suppressed
Glipizide Er	Glipizide	50	suppressed
Metformin Hcl Er	Metformin Hcl	50	12
Clopidogrel	Clopidogrel Bisulfate	48	14
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	48	12
Benazepril Hcl	Benazepril Hcl	47	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	47	suppressed
Memantine Hcl	Memantine Hcl	47	suppressed
Alprazolam	Alprazolam	40	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	39	23
Glimepiride	Glimepiride	39	suppressed
Breo Ellipta	Fluticasone/Vilanterol	36	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	suppressed
Jardiance	Empagliflozin	36	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	36	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Alendronate Sodium	Alendronate Sodium	33	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	33	suppressed
Risperidone	Risperidone	30	suppressed
Repatha Sureclick	Evolocumab	29	suppressed
Enalapril Maleate	Enalapril Maleate	28	suppressed
Fluticasone Propionate	Fluticasone Propionate	28	suppressed
Amoxicillin	Amoxicillin	27	24
Buspirone Hcl	Buspirone Hcl	27	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	24
Pregabalin	Pregabalin	27	suppressed
Synthroid	Levothyroxine Sodium	27	suppressed
Verapamil Er	Verapamil Hcl	27	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Topiramate	Topiramate	26	suppressed
Megestrol Acetate	Megestrol Acetate	25	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	23	suppressed
Klor-Con M10	Potassium Chloride	23	suppressed
Cefuroxime	Cefuroxime Axetil	22	19
Famotidine	Famotidine	22	suppressed
Losartan Potassium	Losartan Potassium	22	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Midodrine Hcl	Midodrine Hcl	20	suppressed
Mupirocin	Mupirocin	20	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	17
Prednisone	Prednisone	19	14
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Carbamazepine	Carbamazepine	18	suppressed
Cephalexin	Cephalexin	18	16
Clonidine Hcl	Clonidine Hcl	18	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	17	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Primidone	Primidone	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	16	suppressed
Rivastigmine	Rivastigmine Tartrate	16	suppressed
Testosterone Cypionate	Testosterone Cypionate	16	suppressed
Tramadol Hcl	Tramadol Hcl	16	suppressed
Anastrozole	Anastrozole	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	13
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Liothyronine Sodium	Liothyronine Sodium	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Tiadylt Er	Diltiazem Hcl	13	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	12	suppressed
Torsemide	Torsemide	12	suppressed
Icosapent Ethyl	Icosapent Ethyl	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Ozempic	Semaglutide	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error